Stay updated with breaking news from Opus Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, has raised an additional $4.5 million in funding from investors.
The year's cohort of six recipients include a journalist, an astrophysicist, and Nobel Prize winners.
Penn will award Menzel, a Tony award-winning actress, an honorary Doctor of Arts at the ceremony, according to an announcement from Vice President and University Secretary Medha Narvekar.
RTP gene therapy startup Opus Genetics has acquired the rights to two pre-clinical product candidates to treat inherited retinal diseases from New Jersey biopharm company Iveric Bio.